MERIBANK BIOTECH CO., LTD
宣捷幹細胞生技股份有限公司
Leave your email for change alerts (optional)
2001Founded
NT$960MPaid-in capital
0Plants
2Certifications
2Patents
NT$100–500MRevenue band
- Unified Business No.
- 12685908
- Industry
- Tobacco Manufacturing (1,186)
- Listing
- Emerging stock (TPEx) (359) 4724
- Founded
- 2001-02-13
- Paid-in capital
- NT$ 959,764,060
- Phone
- 02-89787777
- Website
- http://www.meribank.com.tw
- Exporter
- Yes — registered with the Trade Administration
- Annual revenue band
- NT$100–500M
- Ownership
- Group subsidiary / corporate-held · REON BIOTECH CO., LTD.
- Representative tenure
- In office since 2018-07 (8 yrs); last handover 2018-07 (same surname)
- Growth & profitability
- Revenue 2026-09 YoY -25.4%, year-to-date -25.6%
Gross margin 30.5%, operating margin -34.9%, net margin -39.1% (2026-Q2 YTD) - Compliance record
- Labour Standards Act penalties: 1 case(s) in 5 years, latest 2026-07-30, fines NT$ 20,000 (Art. 30) — matched by company name
Certifications 2
- ISO 17025 (76)Self-reported
- ISO 9001 (4,293)Self-reported
Processes & materials 3
- Biotechnology (664) · Company nameSelf-reported
- Testing & inspection (1,056) · Assembly & inspectionSelf-reported
- Cleanroom production (392) · Assembly & inspectionSelf-reported
Patents 2
- 2021 Method for determining risk of developing preeclampsia
- 2021 Method for determining risk of preeclampsia occurrence
Recent changes 1
- PenaltiesLabour Standards Act penalties: latest case 2026-07-30; 1 case(s) in 5 years, fines NT$ 20,000
RSS feed · Recent changes at Taiwanese manufacturers →
Similar companies 10
- Kuang Li Biotech Holdings Co., Ltd. Listed (TWSE) NT$100–500M
Shared: Biotechnology, Testing & inspection - GREAT NOVEL THERAPEUTICS BIOTECH & MEDICALS CORPORATION Emerging stock (TPEx) < NT$20M
Shared: Biotechnology, General R&D services - TWI BIOTECHNOLOGY, INC. Emerging stock (TPEx) NT$100–500M estimated
Shared: General R&D services - PELL BIO-MED TECHNOLOGY CO., LTD. Listed (TWSE) NT$20–100M
Shared: Biotechnology, Testing & inspection - Han Kang Biotech Co. (Cayman) Listed (TWSE) NT$20–100M
Shared: Biotechnology - Chuan Yu Biotech Holdings Co., Ltd. Listed (TWSE) NT$1–5B
Shared: Biotechnology - BTL INC. Listed (TPEx) NT$1–5B
Shared: Testing & inspection, ISO 17025 - WENDELL INDUSTRIAL CO., LTD. Listed (TPEx) NT$1–5B
Shared: Testing & inspection, ISO 17025 - BIOLASCO TAIWAN CO., LTD. Listed (TPEx) NT$100–500M
Shared: Testing & inspection, ISO 17025 - LYTONE ENTERPRISE, INC. Emerging stock (TPEx) NT$0.5–1B
Shared: General R&D services